Learn more

ANADYS PHARMACEUTICALS INC

Overview
  • Total Patents
    378
  • GoodIP Patent Rank
    196,512
About

ANADYS PHARMACEUTICALS INC has a total of 378 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BABU YARLAGADDA S, NANJING CAVENDISH BIO ENGINEERING TECHNOLOGY CO LTD and DAIICHI SANKYO COMPANY.

Patent filings per year

Chart showing ANADYS PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Webber Stephen E 134
#2 Rueden Erik J 82
#3 Haley Gregory J 76
#4 Lennox Joseph R 76
#5 Averett Devron R 63
#6 Ruebsam Frank 56
#7 Zhou Yuefen 50
#8 Kucera David 46
#9 Tran Chinh Viet 42
#10 Viertelhaus Martin 40

Latest patents

Publication Filing date Title
SG195288A1 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
WO2012158271A1 Bridged polycyclic compounds as antiviral agents
KR20120092142A Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
NZ593021A Method of preparing deoxyribofuranose compounds
WO2010042834A1 A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
TW201026675A 5,6-dihydro-1H-pyridin-2-one compounds
CN102316871A [1,2,4]thiadiazine 1,1-dioxide compounds
WO2009026292A1 Dosing methods for treating disease
US2008292588A1 1-methyl-benzo[1,2,4]thiadiazine 1-oxide derivatives
US2010034773A1 5,6-dihydro-1H-pyridin-2-one compounds
WO2008073987A1 Saturated fused [1,2-b] pyridazinone compounds
TW200840572A 5,6-dihydro-1H-pyridin-2-one compounds
CN101605457A P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-ss-d-ribofuranosyl)-3h-thiazole [4, 5-d] pyrimidine-2-one and methods for preparation
BRPI0717741A2 PREPARATION METHODS, METHOD OF PREPARATION, SUBSTITUTED SULFONIL COMPOUND REDUCTION METHOD, PHARMACEUTICAL COMPOSITION TREATMENT OR DISEASE PREVENTION
US2008188466A1 Pyridazinone compounds
WO2008082725A1 Pyridazinone compounds
US2009062263A1 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
EP2019113A1 New Crystalline Salts of 5-Amino-3-(2',3'-di-O-acetyl-beta-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one
US2008020989A1 Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines
EP2014771A1 Continuous enzymatic hydrolysis process